At a glance
- Originator Triangle Pharmaceuticals
- Developer Avid Corporation; Triangle Pharmaceuticals
- Class Amides; Antivirals; Benzene derivatives
- Mechanism of Action Hepatitis B virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 10 Jun 1999 Preclinical development for Hepatitis B in USA (Unknown route)